Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 September 1990:
Vol. 249. no. 4976, pp. 1552 - 1555
DOI: 10.1126/science.2218496
Prev | Table of Contents | Next

Articles

Science, Vol 249, Issue 4976, 1552-1555
Copyright © 1990 by American Association for the Advancement of Science

articles

Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2

R Lupu, R Colomer, G Zugmaier, J Sarup, M Shepard, D Slamon, and ME Lippman

Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC 20007.

The erbB2 oncogene encodes a 185-kilodalton transmembrane protein whose sequence is similar to the epidermal growth factor receptor (EGFR). A 30-kilodalton factor (gp30) secreted from MDA-MB-231 human breast cancer cells was shown to be a ligand for p185erbB2. An antibody to EGFR abolished the tyrosine phosphorylation induced by EGF and transforming growth factor-alpha (TGF-alpha) but only partially blocked that produced by gp30 in SK-BR-3 breast cancer cells. In two cell lines that overexpress erbB2 but do not expresss EGFR (MDA-MB-453 breast cancer cells and a Chinese hamster ovary cell line that had been transfected with erbB2), phosphorylation of p185erbB2 was induced only by gp30. The gp30 specifically inhibited the growth of cells that overexpressed p185erbB2. An antibody to EGFR had no effect on the inhibition of SK-BR-3 cell colony formation obtained with gp30. Thus, it appeared that gp30 interacted directly with the EGFR and erbB2. Direct binding of gp30 to p185erbB2 was confirmed by binding competition experiments, where gp30 was found to displace the p185erbB2 binding of a specific antibody to p185erbB2. The evidence described here suggests that gp30 is a ligand for p185erbB2.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
SHP-2-Dependent Mitogen-Activated Protein Kinase Activation Regulates EGFRvIII but not Wild-Type Epidermal Growth Factor Receptor Phosphorylation and Glioblastoma Cell Survival.
Y. Zhan and D. M. O'Rourke (2004)
Cancer Res. 64, 8292-8298
   Abstract »    Full Text »    PDF »
HMG-I(Y) Recognizes Base-unpairing Regions of Matrix Attachment Sequences and Its Increased Expression Is Directly Linked to Metastatic Breast Cancer Phenotype.
W.-M. Liu, F. K. Guerra-Vladusic, S. Kurakata, R. Lupu, and T. Kohwi-Shigematsu (1999)
Cancer Res. 59, 5695-5703
   Abstract »    Full Text »    PDF »
Ribozyme-mediated Down-Regulation of ErbB-4 in Estrogen Receptor-positive Breast Cancer Cells Inhibits Proliferation Both in Vitro and in Vivo.
C. K. Tang, X.-Z. W. Concepcion, M. Milan, X. Gong, E. Montgomery, and M. E. Lippman (1999)
Cancer Res. 59, 5315-5322
   Abstract »    Full Text »    PDF »
Heregulin {beta}1-activated Phosphatidylinositol 3-Kinase Enhances Aggregation of MCF-7 Breast Cancer Cells Independent of Extracellular Signal-regulated Kinase.
M. Tan, R. Grijalva, and D. Yu (1999)
Cancer Res. 59, 1620-1625
   Abstract »    Full Text »    PDF »
Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
H. Jinno, M. G. Steiner, R. G. Mehta, M. P. Osborne, and N. T. Telang (1999)
Carcinogenesis 20, 229-236
   Abstract »    Full Text »    PDF »
The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells.
B. D. Cohen, P. A. Kiener, J. M. Green, L. Foy, H. P. Fell, and K. Zhang (1996)
J. Biol. Chem. 271, 30897-30903
   Abstract »    Full Text »    PDF »
Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina.
O Bermingham-McDonogh, K. McCabe, and T. Reh (1996)
Development 122, 1427-1438
   Abstract »    PDF »
Heregulin Activation of Extracellular Acidification in Mammary Carcinoma Cells Is Associated with Expression of HER2 and HER3.
S. D. H. Chan, D. M. Antoniucci, K. S. Fok, M. L. Alajoki, R. N. Harkins, S. A. Thompson, and H. G. Wada (1995)
J. Biol. Chem. 270, 22608-22613
   Abstract »    Full Text »    PDF »
HER4 Expression Correlates with Cytotoxicity Directed by a Heregulin-Toxin Fusion Protein.
C. B. Siegall, S. S. Bacus, G. D. Plowman, B. Mixan, D. Chace, D. M. Chin, A. Goetze, J. M. Green, I. Hellström, and H. P. Fell (1995)
J. Biol. Chem. 270, 7625-7630
   Abstract »    Full Text »    PDF »
Expression of neu Antigen in Normal Lactating and Prepartum Mammary Epithelial Cells.
B. M. Kacinski, J. Nguyen, and D. Carter (1995)
Reproductive Sciences 2, 51-56
   Abstract »    PDF »
A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells.
V De Corte, C De Potter, D Vandenberghe, N Van Laerebeke, M Azam, H Roels, M Mareel, and J Vandekerckhove (1994)
J. Cell Sci. 107, 405-416
   Abstract »    PDF »
Identification of Heregulin, a Specific Activator of p185erbB2.
W. E. Holmes, M. X. Sliwkowski, R. W. Akita, W. J. Henzel, J. Lee, J. W. Park, D. Yansura, N. Abadi, H. Raab, G. D. Lewis, et al. (1992)
Science 256, 1205-1210
   Abstract »    PDF »
Adenovirus-directed expression of Q227L-Galpha s inhibits growth of established tumors of later-stage human breast cancer cells in athymic mice.
T. A. Santore, Y. Chen, M. J. Smit, and R. Iyengar (2002)
PNAS 99, 1671-1676
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)